CXCR5 and infection: The fusion constructs demonstrated 5–8-fold improvements in potency compared to GRFT alone in C-C chemokine receptor type 5 (CCR5)-tropic or C-X-C chemokine receptor type 5 (CXCR5)-tropic cell-cell fusion assays and single-round infection assays [23].